ER+/HER2- METASTATIC BREAST CANCER
Clinical trials for ER+/HER2- METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ER+/HER2- METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for ER+/HER2- METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could match resistant breast cancer to best drug
Disease control Recruiting nowThis phase 2 trial is testing whether a liquid biopsy (a simple blood test) can help choose the right treatment for people with ER+/HER2- metastatic breast cancer that has stopped responding to standard therapies. About 484 participants will be assigned to one of several drug arm…
Matched conditions: ER+/HER2- METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Zapping resistant tumors: could radiation keep breast cancer therapy working longer?
Disease control Recruiting nowThis phase 2 trial tests whether giving precise radiation (SBRT) to a few growing cancer spots can help women with ER+/HER2- metastatic breast cancer stay on their current hormone therapy or CDK4/6 inhibitor longer. The study enrolls 48 women whose cancer has started to progress …
Matched conditions: ER+/HER2- METASTATIC BREAST CANCER
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
700 breast cancer patients join study to track how CDK4/6 drugs work in real life
Knowledge-focused Recruiting nowThis study follows 700 adults with advanced or metastatic breast cancer who are taking CDK4/6 inhibitors (ciclib drugs). Researchers collect blood, tissue, and fluid samples to understand how the cancer responds, why resistance develops, and how well patients do over time. The go…
Matched conditions: ER+/HER2- METASTATIC BREAST CANCER
Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC